Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
10,000
-10,000
-50% -$1.21M ﹤0.01% 297
2026
Q1
$3.27M Sell
20,000
-18,200
-48% -$2.8M 0.01% 267
2025
Q4
$6.65M Hold
38,200
0.02% 244
2025
Q3
$5.5M Buy
38,200
+1,500
+4% +$184K 0.01% 253
2025
Q2
$3.69M Sell
36,700
-23,300
-39% -$1.78M 0.01% 259
2025
Q1
$4.58M Hold
60,000
0.01% 261
2024
Q4
$4.14M Buy
60,000
+19,500
+48% +$1.4M 0.01% 258
2024
Q3
$2.96M Buy
+40,500
New +$2.99M 0.01% 280

Other funds holding INSM

BAMCO Inc's INSM Position: Q2 2026 in Review

BAMCO Inc reduced its Insmed (INSM) stake by 50% in Q2 2026, selling an estimated $1.21M and leaving 10,000 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #297.

BAMCO Inc first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.65M in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • BAMCO Inc held 10,000 shares of Insmed worth $1.07M as of Q2 2026.
  • BAMCO Inc sold 10,000 Insmed shares in Q2 2026, an estimated $1.21M.
  • Insmed made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #297 holding.
  • BAMCO Inc first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • BAMCO Inc's Insmed position peaked at $6.65M in Q4 2025.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.